Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-26T20:51:39.517Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of ADHD Medication Among Danish Children and Adolescents from 2010-2020 - A Nationwide Study

Published online by Cambridge University Press:  01 September 2022

M. Stoltz-Andersen ,
R. Wesselhoeft ,
M. Ernst  and
L. Rasmussen
M. Stoltz-Andersen*
Affiliation:
University of Southern Denmark, Ist - Clinical Pharmacology, Pharmacy And Environmental Medicine, Odense M, Denmark
R. Wesselhoeft
Affiliation:
University of Southern Denmark, Ist - Clinical Pharmacology, Pharmacy And Environmental Medicine, Odense M, Denmark
M. Ernst
Affiliation:
University of Southern Denmark, Ist - Clinical Pharmacology, Pharmacy And Environmental Medicine, Odense M, Denmark
L. Rasmussen
Affiliation:
University of Southern Denmark, Ist - Clinical Pharmacology, Pharmacy And Environmental Medicine, Odense M, Denmark
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

To ensure rational drug use, there is a need to continuously monitor the use of ADHD medication among children and adolescents.

Objectives

To describe the use of ADHD medication among Danish children and adolescents from 2010-2020.

Methods

Using the Danish national healthcare registries, we extracted data on filled prescriptions of ADHD medication (including methylphenidate, atomoxetine, guanfacine, dexamphetamine, and lisdexamphetamine) among children (age 6-12 years) and adolescents (age 13-17 years) between 2010-2020. We examined the annual incidence rate and prevalence proportion of ADHD drug use, and the proportion of children and adolescents having an ADHD diagnosis when initiating ADHD medication.

Results

From 2010-2020, the incidence followed a u-shaped trend with an incidence rate of 4.9/1,000 children and 4.4/1,000 adolescents in 2010, decreasing to 3.2/1,000 children and 3.0/1,000 adolescents in 2013, and rising to 4.9/1,000 children and 4.8/1,000 adolescents in 2020. The prevalence for children showed a similar trend, shifting from 17/1,000 in 2010, to 15/1,000 in 2016, and peaking at 19/1,000 children in 2020. However, among adolescents the prevalence increased steadily from 19/1,000 in 2010 to 29/1,000 in 2020. 67% of children and 53% of adolescents initiating ADHD medication had an ADHD diagnosis.

Conclusions

After an initial decline in incidence rates of ADHD medication use among Danish children and adolescents, there has been a rise in use the last five years. The same trend applied for the prevalence among children, whereas the prevalence among adolescents increased steadily over the entire period. More than half of children and adolescents initiating ADHD medication were diagnosed with ADHD.

Disclosure

No significant relationships.

Keywords

children and adolescentdrug utilizationnationwideadhd
Type
Abstract
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S82
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.